Regulatory Science Fellowship Opportunity
LEARN MORE
Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
To stay up-to-date on Harvard-MIT Center for Regulatory Science news and opportunities, contact Leo Pedrelli (leo_pedrelli@hms.harvard.edu)
to be added to our mailing list.
Subscribe to the bi-monthly CRS newsletter below for routine updates on events, Center publications, and more.
See you Fall 2026!
Twitter @Harvardmit_CRS
Please join us Tomorrow, Dec 3rd, for the next #RegSci Forum with guest speaker Marc Lipsitch @mlipsitch, of @HarvardChanSPH! Find registration information below.
Next #RegSci Forum, on December 3rd, will feature guest speaker Marc Lipsitch @mlipsitch, of @HarvardChanSPH, on "Using Simulation and Modeling to Improve Vaccine Evaluation". #Simulation #digitalmedicine #vaccine
Register here: https://harvard.zoom.us/meeting/register/tJEode-hqTwuGNNl5LEdK_zOqTviVpd49yuR
Next #RegSci Forum, on December 3rd, will feature guest speaker Marc Lipsitch @mlipsitch, of @HarvardChanSPH, on "Using Simulation and Modeling to Improve Vaccine Evaluation". #Simulation #digitalmedicine #vaccine
Register here: https://harvard.zoom.us/meeting/register/tJEode-hqTwuGNNl5LEdK_zOqTviVpd49yuR
Thank you to Dr. Matt Prime @mattprime7 for presenting at today's #RegSci Forum. It was truly exciting to hear a start-up perspective and learn about novel methodologies. A big thank you to all who joined this afternoon!
Next #RegSci Forum, on November 12th, will feature guest speaker Dr. Matt Prime @mattprime7 on "Use of Clinical Simulation for the Evolution of Digital Health Solutions". #digitalhealth #digitalmedicine #Simulation
Register here: https://tinyurl.com/2t6fd34c
Thank you to Dr. Aaron Kesselheim @akesselheim for making time to present at our October #RegSci Forum! This highly relevant topic made for an engaging presentation and discussion on the #FDA and its role in building public trust. Thank you to all who attended!
October 1st #RegSci Forum with guest speaker Aaron Kesselheim @akesselheim, Director for Program On Regulation, Therapeutics, and Law @PORTAL_Research on "How Can the FDA Build Public Trust in its Decisions?" #FDA #PublicHealth #pharma
Register: https://rb.gy/w1qiz2